Literature DB >> 867640

Pseudotendons after extraocular muscle surgery.

K C Swan.   

Abstract

Following recession of a rectus muscle, a band of connective tissue designated as a pseudotendon may form between the recessed muscle tendon and the former insertion. The cut edges of the episclera at the former insertion and the sheath of the recessed muscle seem to be the primary sources of this vascularized connective tissue which replaces the avascular episclera which normally underlies the muscles. Repeated operations, excessive inflammatory reaction, injury to the sheath and intermingling of the conjunctiva and deeper wounds are predisposing factors. Pseudotendon formation does not reduce the effectiveness of a recession, because simple excision has little effect on the alignment of the eyes. Sometimes a well-formed pseudotendon can be used as a tendon to achieve additional recession of a previously recessed insertion.

Entities:  

Mesh:

Year:  1976        PMID: 867640      PMCID: PMC1311503     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  4 in total

1.  Recession under Tenon's capsule.

Authors:  K C SWAN; T TALBOT
Journal:  AMA Arch Ophthalmol       Date:  1954-01

2.  Fornix incision for horizontal rectus muscle surgery.

Authors:  M M Parks
Journal:  Am J Ophthalmol       Date:  1968-06       Impact factor: 5.258

3.  Wound healing after operations on the extra-ocular muscles of monkeys.

Authors:  R M Ingram
Journal:  Br J Ophthalmol       Date:  1966-04       Impact factor: 4.638

4.  Fascia in relation to extraocular muscle surgery.

Authors:  K C Swan
Journal:  Arch Ophthalmol       Date:  1970-02
  4 in total
  2 in total

1.  Subconjunctival cyst extending into the orbit.

Authors:  E Başar; H Pazarli; H Ozdemir; G Kaner
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Spontaneous Reattachment of the Medial Rectus After Free Tenotomy.

Authors:  Daniel L Adams; Brittany C Rapone; John R Economides; Jonathan C Horton
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2018-05-29       Impact factor: 1.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.